SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Warns Pfizer Inc. After Children Overdosed in Geodon Study

April 21, 2010 | 
1 min read
Reuters -- U.S. health regulators have warned Pfizer Inc over a series of failures that led to the overdosing of at least 13 children in a clinical trial of its antipsychotic drug Geodon, according to a letter made public on Tuesday.
Clinical research Postmarket research Regulatory
MORE ON THIS TOPIC
New Opportunity, Businessman Walks Up Stairs Finds Exit Big Door
FDA
FDA’s cell and gene therapy head steps down after 1 year
June 30, 2026
 · 
2 min read
 · 
Michael Gibney
Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.
Immunology and inflammation
Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes
June 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Cancer of the brain as tumor growth diagnosis and symptoms of gliomas meningiomas astrocytomas and oligodendrogliomas as diagnosis of symptoms as a paper sculpture.
Regulatory
FDA hits Praxis with 3-month delay for epilepsy drug verdict
June 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Set of crumpled lumps of different paper isolated on yellow background. Gritty dusty dotted effect, vector elements with jagged edges, old notebook sheets.
Regulatory
Amgen’s Tavneos troubles continue as NEJM retracts pivotal publication
June 30, 2026
 · 
2 min read
 · 
Tristan Manalac